NICE to review anti-TNF decision in RA
24 November 2008
NICE has announced that it will review its decision to restrict the use of anti-TNF drugs for patients with rheumatoid arthritis (RA).
Credit: JH Lancy
The U-turn comes after NICE announced last year that people with severe RA would not be permitted to try a second anti-TNF drug.
The decision resulted in an appeal by the Arthritis and Musculoskeletal Alliance (ARMA), the umbrella group for the charity Arthritis Care.
Rachel Haynes, director of public affairs at Arthritis Care, said: ‘We hope that NICE will put the needs of people above costs and reach the right conclusion quickly.
‘Not prescribing these life-transforming drugs to their full potential is like inventing the wheel but not using it because it is cheaper to walk.’
sanjay.tanday@haymarket.com
Comment below and tell us what you think
Additional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
